These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8881277)

  • 1. [Immunotherapy of tumors expressing IGF-I].
    Trojan J; Duc HT; Lafarge-Frayssinet C; Upegui-Gonzales LC; Swiercz B; Bismuth H; Hor F; Anthony D; Guo Y; Ilan J
    C R Seances Soc Biol Fil; 1996; 190(1):165-9. PubMed ID: 8881277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I triple helix gene therapy of rat and human gliomas.
    Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
    Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
    Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression.
    Lafarge-Frayssinet C; Duc HT; Frayssinet C; Sarasin A; Anthony D; Guo Y; Trojan J
    Cancer Gene Ther; 1997; 4(5):276-85. PubMed ID: 9345599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
    Szpechcinski A; Trzos R; Jarocki P; Trojan LA; Oficjalska K; Junkiert A; Wei MX; Mazurek M; Czapiewska JL; Niklinski J; Kopiński P; Chyczewski L; Kasacka I; Trojan J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():98-104. PubMed ID: 15638388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
    Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J
    Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated anti insulin-like growth factor I gene transfer for the treatment of hepatocellular carcinoma.
    Lafarge-Frayssinet C; Martin C; Van Binh PN; Achard-Ellouk S; Duc HT; Frayssinet C; Cardoso G; Desauty G; Warnet JM; Bréchot C; Sarasin A
    Anticancer Res; 2002; 22(6C):3895-904. PubMed ID: 12553010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-I triple helix strategy in hepatoma treatment.
    Upegui-Gonzalez LC; Ly A; Sierzega M; Jarocki P; Trojan L; Duc HT; Pan Y; Shevelev A; Henin D; Anthony D; Nowak W; Popiela T; Trojan J
    Hepatogastroenterology; 2001; 48(39):660-6. PubMed ID: 11462897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of MHC-I and B-7 molecules in rat and human glioma cells expressing antisense IGF-I mRNA.
    Trojan J; Duc HT; Upegui-Gonzalez LC; Hor F; Guo Y; Anthony D; Ilan J
    Neurosci Lett; 1996 Jul; 212(1):9-12. PubMed ID: 8823750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
    Friese MA; Platten M; Lutz SZ; Naumann U; Aulwurm S; Bischof F; Bühring HJ; Dichgans J; Rammensee HG; Steinle A; Weller M
    Cancer Res; 2003 Dec; 63(24):8996-9006. PubMed ID: 14695218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis.
    Ly A; Francois JC; Upegui-Gonzalez LC; Swiercz B; Bedel C; Duc HT; Bout D; Trojan J
    Life Sci; 2000 Dec; 68(3):307-19. PubMed ID: 11191646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines.
    Friend KE; Khandwala HM; Flyvbjerg A; Hill H; Li J; McCutcheon IE
    Growth Horm IGF Res; 2001 Apr; 11(2):84-91. PubMed ID: 11472074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.
    Trojan J; Johnson TR; Rudin SD; Ilan J; Tykocinski ML; Ilan J
    Science; 1993 Jan; 259(5091):94-7. PubMed ID: 8418502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
    Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.
    Paul DB; Barth RF; Yang W; Shen GH; Kim J; Triozzi PL
    Gene Ther; 2000 Jun; 7(12):993-9. PubMed ID: 10871746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosis.
    Ly A; Bouchaud C; Henin D; Sanson M; Delattre JY; Pan Y; Anthony D; Duc HT; Evrard P; Trojan J
    Neurosci Lett; 2000 Mar; 281(1):13-6. PubMed ID: 10686404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I.
    Trojan J; Blossey BK; Johnson TR; Rudin SD; Tykocinski M; Ilan J; Ilan J
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4874-8. PubMed ID: 1594587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of antisense bcl-2 cDNA abolishes tumorigenicity and enhances chemosensitivity of human malignant glioma cells.
    Zhu CJ; Li YB; Wong MC
    J Neurosci Res; 2003 Oct; 74(1):60-6. PubMed ID: 13130506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular endothelial growth factor shRNA mediated by pEGFP-H1 vector plasmid effectively inhibits glioma proliferation: an experimental study].
    Jiang XB; Zhao HY; Zhou F; Liu RE; Zhang FC; Zhao JS
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):547-50. PubMed ID: 15949336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.